Ankerstar Wealth
NKTR icon

Ankerstar Wealth’s Nektar Therapeutics NKTR Stock Holding History

Ankerstar Wealth’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$61 Buy
+1
New +$70 ﹤0.01% 1041

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Ankerstar Wealth's NKTR Position: Q3 2026 in Review

Ankerstar Wealth opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 1 share worth $61. The stake represents ﹤0.01% of the portfolio and ranks #1041 among its holdings.

168 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Ankerstar Wealth held 1 share of Nektar Therapeutics worth $61 as of Q3 2026.
  • Nektar Therapeutics was a new Ankerstar Wealth position in Q3 2026.
  • Nektar Therapeutics made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #1041 holding.
  • 168 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.